Standard Chem & Pharm Co. Ltd.

Total Valuation

Standard Chem & Pharm Co. Ltd. carries a market capitalization of 11.42B, placing it among publicly traded companies globally. Its enterprise value stands at 12.43B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Standard Chem & Pharm Co. Ltd. currently has 178.70M shares outstanding.

Valuation Ratios

Standard Chem & Pharm Co. Ltd. trades at a trailing price-to-earnings ratio of 11.34. The price-to-sales ratio is 1.50, and the price-to-book ratio stands at 2.16.

Enterprise Valuation

On an enterprise value basis, Standard Chem & Pharm Co. Ltd. trades at an EV/EBITDA multiple of 9.14 and an EV/FCF ratio of 5.46. The EV/Sales ratio of 1.77 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.14 provides insight into valuation relative to core operating earnings.

Financial Position

Standard Chem & Pharm Co. Ltd. maintains a current ratio of 2.53, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 12.16, indicating elevated leverage, while an interest coverage ratio of 161.01 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Standard Chem & Pharm Co. Ltd. posts a return on equity of 19.72 and a return on invested capital of 10.93.

Taxes

Over the trailing twelve months, Standard Chem & Pharm Co. Ltd. has paid 258.35M in income taxes, reflecting an effective tax rate of 17.07.

Stock Price Statistics

Standard Chem & Pharm Co. Ltd.'s stock has gained approximately 11.90893% over the past 52 weeks. The 50-day moving average sits at 62.07, while the 200-day moving average is 60.84.

Income Statement

Over the trailing twelve months, Standard Chem & Pharm Co. Ltd. generated 7.02B in revenue and converted that into 927.66M in net income, yielding earnings per share of 7.03. EBITDA reached 1.36B, while operating income came in at 1.36B.

Balance Sheet

Standard Chem & Pharm Co. Ltd. holds 2.39B in cash and equivalents against 1.13B in total debt, resulting in a net debt position of -929.55M. Total book value stands at 4.87B, with working capital of 3.30B providing operational flexibility.

Cash Flow

Standard Chem & Pharm Co. Ltd. produced 1.77B in operating cash flow over the past twelve months. After subtracting -503.33M in capital expenditures, free cash flow totaled 1.26B - equivalent to 7.07 per share.

Margins

Standard Chem & Pharm Co. Ltd. operates with a gross margin of 41.42, reflecting its pricing power and cost economics. The operating margin of 19.37 and net profit margin of 13.21 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Standard Chem & Pharm Co. Ltd.'s most recent stock split took place on August 19, 2011 with a 100:107 split ratio.

Scores

Standard Chem & Pharm Co. Ltd. posts an Altman Z-Score of 4.22, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.